The Village of Newtown has also provided support to the project through tax abatements applied to the buildout of the newly leased facility. Meridian received a JobsOhio Economic Development Grant as part of its commitment to create 45 new jobs and invest more than $7 million in Ohio. JobsOhio and REDI Cincinnati are partnering with Meridian to support its growth on the Meridian Bioscience campus in Newtown, Ohio. commented during the launch of the RADx SM initiative in April 2020 saying, “Now is the time for that unmatched American ingenuity to bring the best and most innovative technologies forward to make testing for COVID-19 widely available.” Meridian Bioscience is one of 27 projects that have moved to Phase 2, with a focus on scaling manufacturing to increase the capacity of testing in the U.S. NIH launched the RADx SM initiative to speed innovation in developing, commercializing, and implementing technologies for COVID-19 testing. “Our customers continue to search for more tests to battle this wave of the coronavirus pandemic and this support from our Federal, State, and Local governments will be instrumental in scaling our manufacturing capacity.” “We are excited to be in the final stages of bringing the Revogene SARS-CoV-2 assay to market,” said Tony Serafini-Lamanna, Executive Vice President – Diagnostics. The expansion will be completed in phases over the coming months and is expected to yield a maximum capacity of 800,000 Revogene ® tests per month by the end of the calendar year 2021. The funding will help Meridian expand production of Revogene ® test kits in the Quebec City facility and build a new semi-automated, state-of-the-art, two-line production facility near the corporate headquarters in the Village of Newtown (Cincinnati, OH). (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase the production capacity of the company’s SARS-CoV-2 molecular diagnostic test on its Revogene ® platform after receiving a $5.5M award from the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM) initiative and an additional grant from JobsOhio. CINCINNATI, Febru(GLOBE NEWSWIRE) – Meridian Bioscience, Inc.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |